Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Chubb
Boehringer Ingelheim
Merck
Queensland Health
Cipla
Daiichi Sankyo
Fish and Richardson

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089624

« Back to Dashboard

NDA 089624 describes REVERSOL, which is a drug marketed by Organon Usa Inc and is included in one NDA. Additional details are available on the REVERSOL profile page.

The generic ingredient in REVERSOL is edrophonium chloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the edrophonium chloride profile page.
Summary for 089624
Tradename:REVERSOL
Applicant:Organon Usa Inc
Ingredient:edrophonium chloride
Patents:0
Therapeutic Class:Antimyasthenic Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 089624

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:May 13, 1988TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
US Army
Medtronic
Argus Health
Cantor Fitzgerald
Fuji
Moodys
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.